Cannabis Bioscience International Holdings, Inc. (CBIH) Receivables (2023 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted Receivables of $1266.0 for Q1 2026, down 94.2% sequentially from $21811.0 in Q4 2025, and down 52.05% YoY from $2640.0 in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) Receivables (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported Receivables for 4 years, with the latest figure at $1266.0 in Q1 2026.
- Quarterly Receivables fell 52.05% year-over-year to $1266.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1266.0 (down 52.05% YoY) and the FY2025 annual result came in at $15535.0, down 22.86% from the prior year.
- Receivables retreated to $1266.0 in Q1 2026 per CBIH's latest filing, from $21811.0 in the prior quarter.
- Over five years, Receivables peaked at $21811.0 in Q4 2025 and troughed at $1266.0 in Q1 2026.
- A 4-year average of $14263.8 and a median of $17041.0 in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables jumped 102.38% in 2024, then tumbled 84.51% in 2025.
- Over 4 years, Receivables stood at $19403.0 in 2023, then dropped by 28.78% to $13819.0 in 2024, then surged by 57.83% to $21811.0 in 2025, then sank by 94.2% to $1266.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $1266.0, $21811.0, and $18121.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1,266.00 |
| Nov 30, 2025 | 21,811.00 |
| Aug 31, 2025 | 18,121.00 |
| May 31, 2025 | 15,535.00 |
| Feb 28, 2025 | 2,640.00 |
| Nov 30, 2024 | 13,819.00 |
| Aug 31, 2024 | 17,176.00 |
| May 31, 2024 | 20,139.00 |
| Feb 29, 2024 | 17,041.00 |
| Nov 30, 2023 | 19,403.00 |
| May 31, 2023 | 9,951.00 |